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The main vector of dengue in America is the mosquito Aedes aegypti, which is infected by dengue virus (DENV) through receptors
of midgut epithelial cells. The envelope protein (E) of dengue virus binds to receptors present on the host cells through its domain III
that has been primarily recognized to bind cell receptors. In order to identify potential receptors, proteins from mosquito midgut
tissue and C6/36 cells were purified by affinity using columns with the recombinant E protein domain III (rE-DIII) or DENV
particles bound covalently to Sepharose 4B to compare and evaluate their performance to bind proteins including putative receptors
from female mosquitoes of Ae. aegypti. To determine their identity mass spectrometric analysis of purified proteins separated by
polyacrylamide gel electrophoresis was performed. Our results indicate that both viral particles and rE-DIII bound proteins with
the same apparent molecular weights of 57 and 67 kDa. In addition, viral particles bound high molecular weight proteins. Purified
proteins identified were enolase, beta-adrenergic receptor kinase (beta-ARK), translation elongation factor EF-1 alpha/Tu, and
cadherin.

1. Introduction
Dengue fever, dengue hemorrhagic fever (DHF), and dengue
shock syndrome (DSS) are the most important arthropodborne diseases nowadays, affecting people living mainly in
tropical and subtropical regions, where environmental conditions favor the proliferation of the mosquito vector Ae.
aegypti, as this has been spread to other regions in the world
likely due to gradual climatic changes [1, 2]. Though, this may
contribute to the spread of this disease, this has not been
demonstrated [3].
The etiological agent of dengue is a positive-stranded
RNA virus containing 3 structural proteins (C, prM, E) and 7
nonstructural proteins (NS1, NS2A, NS2B, NS3, NS4A,
NS4B, and NS5). It belongs to the family Flaviviridae, genus

flavivirus, known as dengue virus (DENV), and includes
serotypes from 1 to 4. Each serotype is also classified into a
series of genotypes or subtypes [3–6]. Dengue virus genotypes differ in virulence, including their human pathogenicity
and epidemic potential.
Dengue virus is transmitted to humans in America
mainly by the mosquito vectors Aedes aegypti [7] infecting
primary human cells such as peripheral blood leukocytes,
blood monocytes/macrophages, dendritic cells, and B lymphocytes [7]. Dengue virus attaches to the host epithelial cell
receptors protein E-mediated [8, 9] and enters the cell mainly
via this receptor by clathrin-dependent endocytosis [10–13].
In mammalian cells, several DENV receptors have been
described [14–19] as well as in mosquito cells; however the
molecular identity of the receptors in mosquito cells has not
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been completely elucidated. The apparent molecular weights
described for these proteins are between 20 to 40 kDa and
57 to 130 kDa in size and bind dengue virus particles in vitro
[8, 20–24]. In addition, Mercado-Curiel et al. [23] reported
that specific antibodies against the membrane proteins R67
and R80 inhibited infection of C6/36 cells. Further, a protein
with molecular mass of 57 kDa was also purified by affinity
chromatography using a DEN2-Sepharose 4B column [23].
Viral envelope (E) protein of DENV as other Flavivirus
has a homology of about 40% among different members of the
family [25], and the crystal structures of this protein revealed
three domains (I, II, and III) containing significant structural
conservation [26–28]. DENV E protein is a class II fusion
protein responsible for host cell attachment, entry, and virusmediated cell membrane fusion.
It has also been shown that domain III of the envelope
glycoprotein is an immunoglobulin-like structure and that
the main viral region interacts with receptors on the host cells
[29–36]. It has been also demonstrated that EIII domain of
DENV-2 inhibits infection of DV on C6/36 cells and mammalian cells, suggesting that EIII domain binds molecules on
the cell membrane that may participate in receptor-mediated
DV entry [37]. However, the molecular mechanism of DENVreceptors has not been characterized in mosquitoes until
now. We would expect that such molecular interactions in
mosquito vector would influence virus passage through the
different mosquito barriers: the first one is that after the virus
established a midgut (MG) infection (MI) by overcoming
the MG infection barrier (MIB): next replication in the
MG epithelium, and then that virus must pass through a
MG escape barrier (MEB) and replicate in other tissues
to establish a disseminated infection (DI). Finally, virus
must infect salivary glands and be shed in the saliva to be
transmitted to a vertebrate host [38, 39].
It is accepted that the mechanisms by which DENV
infects its target host cell should be the major determinant of
the virus cellular tropism and critical for viral pathogenesis.
Erb et al. [37] demonstrated that the FG loop located in DIII,
where DENV2 has an extended loop motif between the F and
G beta strands, was critical for the infection of Aedes aegypti
mosquito MGs and mammalian cells by mutational studies.
In addition, Butrapet et al. [40] identified critical amino acids
within the hinge region of DENV-2, that are vital for virus
fusion and replication. While domain III has already been
used to study immunological and pathological mechanisms
[40–46], its suitability for isolating specific receptors has not
yet been investigated; then, we are showing in this communication the purification of DENV binding proteins from Ae.
aegypti MG tissue and C6/36 cells by affinity chromatography
using particles of DENV-2, -1, and -4 or rE2-DIII covalently
bound to Sepharose 4B. In addition the identity of these
proteins was determined by proteomic analysis.

2. Materials and Methods
2.1. Virus. DENV-2 Jamaica was expanded in Vero cells [47],
purified from the culture supernatants as previously described [48], and kept frozen at −70∘ C until use. Briefly, Vero cells
were cultured at 37∘ C, 2% CO2 in Dulbecco’s Modified
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Eagle’s Medium (DMEM; HyClone, Logan, Utah, USA)
supplemented with 5% heat-inactivated fetal bovine serum
(FBS; Gibco BRL, Gaithersburg, MD, USA), 100 units/mL of
penicillin, and 100 𝜇g/mL of streptomycin. Vero cells (2 ×
106 /100 mm plate) were infected with 0.2 mL of DENV-2
inoculums with an input MOI of 600 PFU/plate and incubated for 10 days. We also included in our studies DENV-1
Hawaii, DENV-2 S1656OAX05 (Asian/American genotype),
DENV-3 H-87, and DENV-4 H-341 strains.
2.2. Virus Purification. Viruses were purified on sucrose
gradients essentially as described by Srivastava et al. [49] with
minor modifications previously described [23]. The virus
was recovered, suspended in PBS, and kept frozen at −70∘ C
until use. The titer of the viral stock was adjusted to 6 ×
106 PFU/mL. Virus purity was examined for total protein and
by RT-PCR and transmission electron microscopy.
2.3. Virus Biotinylation. NHS-coupled biotinyl compounds
have been used to label cell surface proteins previously [8].
The procedure to biotinylate DENV particles was as follow. Briefly, dissolve (+)-Biotin N-hydroxysuccinimide ester
(Sigma, Catalog Number H1759) in DMSO immediately prior
to use protecting solution from the light at a concentration of
11 mg/mL. Purified viruses were biotinylated by suspension of
the viral pellet (2 mg of protein) in 0.8 mL of ice cold Phosphate buffer, pH 7.5 (PB) by adding 0.2 mL of NH-D-Biotin
solution with gentle stirring and incubated overnight at 4∘ C
or 3 h at ambient temperature. Biotinylated virus recovered
after centrifugation at 100,000 ×g for 2 h was suspended in
PBS (500 𝜇L). The degree of biotinylation was determined by
dot blot, and the viral stock was kept at −70∘ C until use [8].
2.4. Mosquito Culture. Aedes aegypti mosquitoes from the
strains DS3 (susceptible to DENV), IBO-11 (refractory to
infection), DMEB (midgut escape barrier), and Mori (collected in Monterrey, México) were laboratory-reared and
maintained at 32∘ C and 80% RH with a 12 h photoperiod
using standard mosquito-rearing procedures [50]. The entire
MG was dissected from more than 1500 mosquitoes at day
5 after egg hatching. The procedure was carried out in 10 𝜇L
phosphate buffered saline (PBS). After dissection, each MG
was rinsed twice in the same solution, quickly removed, and
snap-frozen at −70∘ C until use.
2.5. Protein Extract Preparation. To optimize MG protein
extraction, frozen MGs were homogenized in buffer E
(0.05 M Tris-HCl, pH 7.2, 1 mM EDTA), containing 1 𝜇L/mL
of protease inhibitor cocktail (Sigma P9599) and 0.01, 0.05,
0.1, 0.5, or 1.00% v/v of Triton X-100. Protein extracts were
centrifuged for 10 min at 29000 ×g at 4∘ C. Total protein
concentration was determined as described previously by
Bradford [51].
2.6. Virus Overlay Protein Binding Assay (VOPBA). Mosquito
MG proteins were separated by 10% SDS-PAGE according
to the method described by Laemmli [52] and blotted onto
PVDF membranes (BioRad) by Towbin’s technique [53].
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The procedure was followed as previously described [8]. Previous results in our laboratory have showed that biotinylated
virus recognized the same proteins as compared to virus
without any treatment [8].
2.7. Affinity Chromatography. To perform the affinity chromatography assays, DENV-2, -1, -4 (5.7 × 108 PFU/mL), or
domain III of E protein (500 𝜇g, rE2-DIII) (ProSpec-Tany
TechnoGene LTD) were covalently bound to 1 mL of CNBractivated Sepharose 4B as recommended by the manufacturer
(Amersham Biosciences) as described elsewhere [23]. Both
affinity columns were stored in 0.002% sodium azide at 4∘ C
until use.
Midgut protein extract obtained as described above
(300 𝜇g) was applied to the DENV-Sepharose 4B column,
or rE2-DIII-Sepharose 4B column equilibrated in Buffer E
containing 0.5 M NaCl, and washed with the same buffer
thoroughly. The DENV-2 binding proteins were eluted with
0.1 M glycine-HCl pH 2.7 or buffer E containing 1 M NaCl.
Fractions of 0.500 mL were collected, and the protein concentration was monitored by the Bradford method [51]. Eluted
proteins in each fraction were concentrated by acetoneprecipitation [54], separated by 10% SDS-PAGE (sodium
dodecyl sulfate polyacrylamide gel electrophoresis) [52] and
Coomassie Brilliant Blue or silver stained [55]. Total protein extracts from Ae. aegypti mosquito DS3 (susceptible
to DENV), IBO-11 (refractory to infection), and DMEB
(the membrane escape barrier infected exclusively in the
midgut epithelial cells) strains were also separated by SDSPAGE, and then the proteins that migrated as the purified
proteins (57 and 67 kDa) were also excised from the gels
and the proteomic analysis was carried out (Table 1). Protein
assignment was done by at least two peptide matches.
2.8. Protein Sequencing. The protein bands of interest were
excised from a Coomassie Brilliant Blue R-250-stained
gel, digested with trypsin, and identified by mass spectrometry (3200 TRAP hybrid tandem mass spectrometer,
Applied Biosystem/MDS Sciex, Concord, ON, Canda). LC/
MS/MS analysis of tryptic peptides was carried out using
a NanoAcquity ultraperformance liquid chromatograph
(UPLC) (Waters Corporation), coupled to a Q-ToF Synapt
High Definition Mass Spectrometer (Waters Corporation),
and equipped with a NanoLockSpray ion source. Protein
identification was performed from the MS/MS spectra data
sets using the MASCOT search algorithm (Version 1.6b9,
Matrix Science, London, UK) available at http://www.matrixscience.com/ [56]. Peptide mass tolerance was set to ±1.2 Da
and fragment mass tolerance to ±0.6 Da and the taxonomy
parameter set to all species. Each MS/MS spectrum was also
searched for Ae. aegypti against the data sets at VectorBase
[57].

3. Results
To optimize solubilization of membrane proteins from
mosquito MGs tissue was homogenized with buffer E containing Triton X-100, 0.01, 0.05, 0.1, and 0.5 or 1.00% v/v. Each
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protein extract was separated by SDS-PAGE and stained with
Coomasie Blue. Figure 1(a) shows protein integrity and the
same protein pattern at all Triton X-100 concentrations. To
detect DENV-2 binding proteins, MG protein extracts were
separated by SDS-PAGE, blotted onto a PVDF membrane,
and incubated with biotinylated DENV-2 as mentioned in
the Materials and Methods section. Figure 1(b) displays the
proteins recognized by DENV-2 labeled with biotin. The
optimal concentration of Triton X-100 to extract maximal
DENV binding protein amount was 0.05% v/v (Figure 1(b),
lane 2), since protein bands revealed by DENV-2 labeled
with biotin are of greater intensity. Four major proteins
with molecular masses of 57, 67, 80, and 115 kDa were
observed in all lines (Figure 1(b)). Extraction of proteins
with apparent molecular weight of 67 and 115 (Figure 1(b),
lane 2) with the buffer containing 0.05% v/v Triton X-100
displayed higher densities, suggesting higher concentrations.
This suggests that both proteins may be located at the
membrane. Consequently, protein extraction was subsequently performed at a concentration of 0.05% Triton X-100.
Negative control without virus showed no bands (data not
shown).
In order to recover all proteins bound to the affinity
column, after passing protein extracts from C6/36 cells
through DENV-2-Sepharose 4B column, the proteins were
eluted from independent columns with buffer E containing
1 M NaCl (Figure 2, lines 1 and 2), or 0.1 M Glycine pH 2.7
(Figure 2, lines 3 and 4).
Once the protein extraction procedure was optimized,
dengue virus binding proteins were purified by affinity
chromatography by passing protein extracts from C6-36 cells
through a rE2-DIII-Sepharose 4B column and eluted with
0.1 M Glycine pH 2.7 containing 0.5 M NaCl (Figure 2, lines
6–9). Proteins with apparent molecular weights of 57 and 67
were mainly eluted with this column (Figure 2).
Then, dengue virus binding proteins were purified by
affinity chromatography by passing protein extracts from Ae.
aegypti MG through a DENV-2 or rE2-DIII-Sepharose 4B
columns (Figure 3). Representative patterns of MG proteins
retained and eluted from the column (from at least four
experiments) are shown in Figure 3. Proteins with apparent
molecular weights of 57, 67 kDa were eluted with buffer E
containing 1 M NaCl (Figure 3, lines 1-2) or 0.1 M Glycine pH
2.7 (Figure 3 lines 3-4) from DENV-2 Sepharose 4B column.
Proteins showing the same apparent molecular weights were
eluted from rE2-DIII-Sepharose 4B column with buffer E
containing 1 M NaCl (Figure 3, lines 5) or 0.1 M Glycine pH
2.7 (Figure 3, lines 6-7). The eluted proteins (EP) were stored
at −70∘ C for a further analysis.
3.1. Identification of Mosquito Proteins That Interact with
Dengue Virus. Proteins identified from the MS/MS spectra
data sets using the MASCOT search algorithm [56] with
trypsin enzyme specificity are shown in Table 1. Peptide
sequence of each protein is displayed in Table 2. Proteins are
ordered from the top to the bottom for the number of peptides identified as well as for the number of the experiments.
Proteomic analysis was performed in protein extract purified

Cell/tissue
expression/gel
slice∗∗
C6/36
57 kDa
C6/36
67 kDa
DS3 (extract)
DMEB∗∗∗
67 kDa
DMEB and DS3
67 kDa
C6/36
67 kDa
C6/36
57 kDa
MORI
(extract)
IBO-11
57 kDa
C6/36
80 kDa
Enolase

Cadherin

Beta-adrenergic receptor
kinase1
Beta-adrenergic receptor
kinase2
Translation elongation
factor EF-1 alpha/Tu1
Translation elongation
factor EF-1 alpha/Tu2
Translation elongation
factor EF-1 alpha/Tu3

Q17KK5

Q17KK5

gi|157115805|ref|XP 001658290|

gi|94468780|gb|ABF18239.1|

gi|94468780|gb|ABF18239.1|

gi|94468780|gb|ABF18239.1|

Q17LY6

Q1HR88

Q1HR88

Q1HR88

Q174J9

gi|157121051|ref|XP 001653750|

4

Q17KK5

gi|157114479|ref|XP 001652291|

gi|157121051|ref|XP 001653750|

3

Q174J9

gi|157121051|ref|XP 001653750|

Enolase2

Q17KK5

Accession
swissprot

gi|157114479|ref|XP 001652291|

gi|157121051|ref|XP 001653750|

Enolase1

Enolase

Accession number

Name∗∗∗∗

186427

50,473

50,473

50,473

66217

66217

46621

46621

46621

46621

Predicted
mass (Da)

1653

463

463

463

580

580

433

433

433

433

Size
(aa)

52.0

63

21.8

82.9

40/26.9

40/26.9

75

20.2

60.5

76.1

Mascot
score

4.74

9.61

9.61

9.61

6.74

6.74

5.6

5.6

5.6

5.6

Theoretical
isoelectric
point∗

∗∗∗

∗∗

1

2

1

1

1

1

2

1

1

4

Number of
peptides

Affinity chromatography was performed with DENV-2, -1, or -4.
Bands of interest were excised at the molecular weight of interest (57 or 67 kDa).
Total extract of MGs from Ae. aegypti mosquitoes strain DMEB was separated by SDS-PAGE and the band with apparent molecular weight of 67 kDa was excised for a further analysis.
∗∗∗∗
Superscript number in the name of the protein indicates the number of the experiment.

∗

DENV-4

None

DENV-2

DENV-2

DENV-4

DENV-1

None

DENV-2

DENV-2

DENV-2

DENVSepharose
4B∗

Table 1: Mosquito proteins bound to DENV.

1%

10.8

1.7

5.4

2.6

2.6

13

1.4

7.4

15.9

Protein
coverage
(%)

4
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(kDa)

1

5
2

3

4

5

(kDa)

250

250

130

130

95

95

72

72

1

2

3

4

5

115
80
67
64

64
55

55

36

36

28

28

17

17
(a)

(b)

Figure 1: Midgut total protein extraction with Triton X-100 and VOPBA. (a) Proteins were extracted from mosquito MG tissue at different
Triton X-100 concentrations, separated by SDS-PAGE, and stained with Coomasie Blue. Triton X-100 concentrations were 0.01, 0.05, 0.1,
0.5, and 1% corresponding to lane 1 to 5, respectively. (b) Proteins, separated by SDS-PAGE, were blotted onto PVDF and incubated with
biotinylated DENV-2 and then with AP-Streptavidin. Proteins recognized by DENV-2 were developed with BCIP/NBT according to the
procedure previously described [8]. The apparent molecular weights of these proteins are shown on the right side of (b). Molecular weight
markers are shown on the left side in (a) and (b).
1

2

3

4

6

5

7

8

9

250
130
95
72
67
57

55

67
57

50
45
36
28

Figure 2: Affinity chromatography of C6/36 cell extracts. Proteins were purified from C6/36 cells by affinity chromatography using DEN-2, -1,
-4, or rE2-DIII-Sepharose 4B column as described in the methods section. Aliquots of 500 𝜇L were collected from each column and proteins
were acetone-precipitated. Proteins eluted from DENV-2-Sepharose 4B columns with buffer E containing 1 M NaCl are displayed in lines 1
and 2, or 0.1 M Glycine pH 2.7 in lines 3 and 4. Proteins eluted from rE2-DIII-Sepharose 4B column with 0.1 M Glycine pH 2.7 are displayed
in lines 6–9. Proteins were separated by 10% SDS-PAGE and Coomassie Brilliant Blue or silver stained. The apparent molecular weights of
these proteins are shown on the right side. Molecular weight markers (line 5) are shown on the left side.
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(kDa)

1

2

3

4

5

6

7

250
130
100
72

67
57

55

36

28

Figure 3: Affinity chromatography of MG protein extracts. MG proteins were purified from extracts of different Ae. aegypti strains (DMEB,
DS3, IBO-11, or Mori) by affinity chromatography using DENV-2, -1, -4 or rE2-DIII-Sepharose 4B column as described in Section 2. Midgut
proteins were eluted from DENV-2-Sepharose 4B columns with buffer E containing 1 M NaCl (lines 1-2), or 0.1 M Glycine pH 2.7 (lines 3-4)
and from rE2-DIII-Sepharose 4B column with 1 M NaCl (line 5) or 0.1 M Glycine pH 2.7 containing 0.5 M NaCl (line 6-7). Aliquots of 500 𝜇L
were collected from each column and proteins were acetone-precipitated and separated by 10% SDS-PAGE and Coomassie Brilliant Blue or
silver stained. The apparent molecular weights of these proteins are shown on the right side. Molecular weight markers are shown on the left
side.

by the affinity columns or separated by SDS-PAGE and then
excised from the gel.
Proteomic analysis of proteins obtained from total protein
extracts of Ae. aegypti mosquito DS3, IBO-11, and DMEB
strains separated by SDS-PAGE that migrated as the purified
proteins (57 and 67 kDa) with at least two peptide matches
is shown in Table 1. The proteins identified were enolase,
beta-ARK, translation elongation factor EF-1 alpha/Tu, and
cadherin. Translation elongation factor EF-1 alpha/Tu and
cadherin had been identified previously, thus ensuring that
the procedure described in this work is suitable to the identified proteins bound to DENV and E protein domain III. Peptide sequence AKPGAEAHPPFRQHK has partial alignment
with beta-ARK (ref|XP 001652291|) and with ATP-dependent
RNA helicase (ref|XP 001648042.1|); however, the identification of beta-ARK was confirmed by the match of ESQELLGSMAKK peptide with beta-ARK identified in two mosquito
strains (DS3 and DMEB). Although, cadherin is showing only
one peptide, the peptide match to this protein has a very
high score of 52 (16/17 amino acids). Proteins identified in
C6/36 cells or mosquito MGs from DMEB, DS3, IBO-11, or
Mori strains are also included in Table 1. Manual analysis was
used to confirm peptide identity (Figure 4). Peptide sequence
coverage was 35% for enolase, 2.6% for beta-ARK, and

20% for translation elongation factor EF-1 alpha/Tu. Because
translation elongation factor EF-1 alpha/Tu matched two
proteins, we manually verified mass spectra for presence of
unique peptides for each homologous assignment. In Figure 5
we demonstrate the alignment for these two homologous
proteins EJY57625 and ABF18239 and peptides identified
in each of those two proteins. Peptides NNPPKQAA and
K.GASDFTAQVIVLNHPGQIANGYTPVLDCHTAVIACKFAEIQQK.V were specific for protein EJY57625 (Figure 5).

4. Discussion
Flavivirus vector competence studies in Ae. aegypti have
indicated that the MIB is a major determinant of transmission
[58, 59] and have shown wide variation among Ae. aegypti
populations and flaviviruses including DENV [9, 38, 60].
Studies on mosquito receptors have displayed protein receptors on MG epithelial cells that may be the base to develop
a strategy to control mosquito vector through blocking virus
infection. In order to elucidate the nature of these receptors,
mass spectrometry-based proteomic analysis of the purified
proteins was performed. In our study, we are showing the
isolation of proteins by affinity columns bound to the virus
or domain III of the E protein of dengue 2 virus. Considering
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Table 2: Distinct host peptides identified by mass spectrometry bound to DENV.
Cell/tissue expression Protein name

Experment
Peptide identified
number

Score

K.EALNLIQDAIAK.A
R.GNPTVEVDLVTDLGLFR.A
K.VNQIGTVTESINAHLLAK.K
R.SGETEDTFIADLVVGLSTGQIK.T
FGLDATAVGDEGGFAPNILNNKEALDLINEAISK
GVLKAVTQ
R.AAVPSGASTGVHEALELR.D
K.NLILPVPAFNVINGGSHAGNKQAMQEFMILPTGACSFTEAMK.M

45.6
62.1
76.1
76.1
60.5
20.2
53.2
21.7

1

ESQELLGSMAKK

40.1

2
3

ESQELLGSMAKK
AKPGAEAHPPFRQHK

40.1
26.9

1

SGDAAIVNLVPSWPLCVESFQEFPPLGR

82.9

Mori (extract)

2

21.8

IBO

3

NNPPKQAA
K.GASDFTAQVIVLNHPGQIANGYTPVLDCHTAVIACKFAEIQQK.V
R.LPLQDVYK.I

C6/36 (57 kDa)

Enolase

1

C6/36 (67 kDa)
DS3

2
3

DMEB (67 kDa)

4

DMEB (67 kDa)

Beta-adrenergic
receptor kinase

DS3 (67 kDa)
C6/36 (67 kDa)
C6/36 (57 kDa)

C6/36 (80 kDa)

Translation
elongation factor
EF-1 alpha/Tu

Cadherin

1

FLIDYGSGTLELRIATK

63
52

∗

Proteomic analysis was performed in protein from C6/36 cells, mosquito MGS purified by affinity chromatography (extract), or in the bands of interest excised
after separation by SDS-PAGE.

that Ae. aegypti MG is the best candidate to disrupt the virus
life cycle within the mosquito because it is the earliest interface between insect and virus and that DENV attachment to
MG epithelial cell receptors is also critical for understanding
the initial virus-vector interactions, this will help to explain
MIB to DENV infection and variations in vector competence.
Accordingly, identification of viral receptors in the MG
would represent a critical step in understanding vector
competence and designing possible targets for preventing
viral entry to cells and therefore inhibiting the infection.
Published data have shown that domain III of the viral E
protein is involved in target cell recognition [29] and binding
of host cell surface receptors [32, 34–37]. Consequently,
identification of dengue virus binding proteins by affinity
chromatography using rE2-DIII will help to understand virus
cell entry and to design strategies to block virus infection in
the mosquito cells. Thus, in order to purify DENV binding
proteins, rE2-DIII or viral particles were covalently bound to
Sepharose 4B matrix.
Our results suggest that purified proteins by rE2-DIIISepharose 4B affinity column correspond to the same proteins purified by dengue particles with apparent molecular
weights of 57 and 67 that were also consistently and previously reported in C6/36 cell membranes [23]. Specific antibodies against the 67 kDa protein inhibited virus infection
[8, 23]. Although, DENV-Sepharose 4B bound additional
proteins, we focused our studies to the proteins with apparent
molecular weight of 57 and 67 bound to DENV particles
and E protein domain III (Figures 2 and 3, Table 1). We also
showed that DENV-1, -2, and -4 bound the same proteins with
apparent molecular weights of 57 and 67 kDa.

These results are very important since the identity of
specific MG mosquito proteins bound to viral particles and
domain III of E protein has not been previously reported. The
proteins identified by the proteomic analysis were enolase,
elongation factor 1, beta-ARK, and cadherin. Enolase is a glycolytic enzyme and has been found in small vesicles outside
the cell [61, 62]; it binds to plasminogen and helps pathogens
to invade [63]. Enolase is also found in viral particles [64–
66] and is required for the transcription of Sendai virus
[67]. Furthermore, enolase has been identified in the MG
brush border of Ae. aegypti mosquitos [68]. We identified
enolase in protein extracts of C6/36 cell, and in the MG of
Ae. aegypti mosquitoes from DS3 and DMEB strains and also
showed that this protein is bound to DENV-2. In our previous
reports we established that the 67 kDa protein is a membrane
DENV binding protein [8, 9]. Therefore, our results agree
with previous reports as enolase is in the brush border of
mosquito MGs [68]; This reinforces the idea that enolase may
be a DENV receptor of Ae. aegypti MGs. In addition, enolase
has been also reported to bind to West Nile and DENV virus
envelope and capsid proteins, respectively [69].
The second protein identified by the proteomic analysis
was the beta-ARK with apparent molecular weight of 67,000.
This protein specifically phosphorylates the agonist-occupied
form of the beta-adrenergic and closely related receptors,
probably inducing a desensitisation of them in higher eukaryotic organisms. This kinase is a member of the G proteincoupled receptor kinase (GRKs) family and catalyzes the
phosphorylation of the activated forms of the beta-adrenergic
receptor (beta-AR). As member of GRKs, this protein is
also very important, because it has been implicated in
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Figure 4: Identification of enolase, beta-adrenergic receptor kinase, and translation elongation factor EF-1 alpha/Tu as DENV-binding
proteins by LC MS/MS analysis of the excised protein bands corresponding to the apparent molecular weights of 57 and 67 kDa. The
colored sequences represent the amino acid peptides identified as enolase (a), beta-ARK (b), and translation elongation factor EF-1
alpha/Tu (c) using MS/MS spectrometry after in-gel digestion of the protein-staining band (Tables 1 and 2). The protein sequence refers
to gi|157121051|ref|XP 001653750|, gi|157114479|ref|XP 001652291|, and gi|94468780|gb|ABF18239.1|, respectively.
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Figure 5: Amino acid sequence analysis of two different translation elongation factors EF-1 alpha/Tu. Alignment of these elongation factors
(EJY57625 and ABF18239) identified in C6/36 cells, and MGs of Ae. aegypti mosquitoes of the IBO-11 and MORI strains is shown. Identified
peptides are shown in red color.
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the specific phosphorylation on membrane protein receptors
and in the regulation of signal transduction mechanisms
[70]. Furthermore, beta-ARK also may help virus endocytosis facilitating receptor endocytosis, similarly to beta-ARK
reported to directly interact with phosphoinositie-3-kinase
(PI3K) promoting its membrane localization, phosphoinositide production, AP-2 adaptor protein recruitment to the
receptor, and receptor endocytosis [71]. This protein was
identified in C6/36 cells and DMEB, and DS3 Ae. aegypti
mosquito strains.
The translation elongation factor EF-1 alpha/Tu was the
third identified protein in C6/36 cells and MGs of Ae. aegypti
mosquitoes of the DMEB and IBO-11 strains purified by
affinity chromatography using DENV-2 and -4. Previously,
this protein was also identified as an NS4 binding protein
of DENV and WNV [69]. Furthermore, it has been also
reported that DENV envelope protein binds to cadherin [69].
Furthermore, cadherin identified in this work has also been
reported to bind to DENV envelope protein [60].
The data in the present paper strongly support that
enolase may be a receptor for DENV-2, in MG cells from Ae.
aegypti, and this protein may correspond to the 57 or 67 kDa
protein previously reported [8, 9]. Differences in molecular
weight mass may be due to posttranslational modifications,
residual protease activity, or association with other molecules
as has been formerly reported.
In addition, the procedure described here may be very
useful in future studies to determine the proteins that bind
to different domains of E protein or to other viral proteins.
To the best of our knowledge, this is the first paper that
displays a method to purify Ae. aegypti MG proteins by
affinity chromatography by means of viral particles compared
to rE2-DIII and establish the identity of the proteins with
apparent molecular weights of 57 and 67 kDa.

5. Conclusions
This study identified enolase, beta-ARK, translation elongation factor EF-1 alpha/Tu, and cadherin mosquito as binding
proteins that may play important roles as host factors during
viral infection of mosquito cells. Enolase, beta-ARK, and
cadherin may serve as DENV receptors, and translation
elongation factor EF-1 alpha/Tu may be very important
during virus replication. All proteins were identified in C6/36
cells and in the Ae. aegypti DS3, DMEB, and IBO-11, and Mori
strains that differ in their vector competence for DENV; then
we are suggesting that all mosquito strains of Ae. aegypti and
C6/36 cells from Ae. albopictus interact probably with the
same protein domain. In addition, the protein with the same
apparent molecular weight was bound by DENV-1, -2, and -4
and rE2-DIII. Future studies will be necessary to determine
the specific role of each protein in each strain to know how
they participate in vector competence.
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at 2 Å resolution,” Nature, vol. 375, no. 6529, pp. 291–298, 1995.
[27] Y. Modis, S. Ogata, D. Clements, and S. C. Harrison, “A ligandbinding pocket in the dengue virus envelope glycoprotein,”
Proceedings of the National Academy of Sciences of the United
States of America, vol. 100, no. 12, pp. 6986–6991, 2003.
[28] Y. Modis, S. Ogata, D. Clements, and S. C. Harrison, “Variable
surface epitopes in the crystal structure of dengue virus type
3 envelope glycoprotein,” Journal of Virology, vol. 79, no. 2, pp.
1223–1231, 2005.
[29] Y. Chen, T. Maguire, and R. M. Marks, “Demonstration of
binding of dengue virus envelope protein to target cells,” Journal
of Virology, vol. 70, no. 12, pp. 8765–8772, 1996.
[30] W. D. Crill and J. T. Roehrig, “Monoclonal antibodies that bind
to domain III of dengue virus E glycoprotein are the most
efficient blockers of virus adsorption to vero cells,” Journal of
Virology, vol. 75, no. 16, pp. 7769–7773, 2001.

BioMed Research International
[31] J. J. H. Chu, R. Rajamanonmani, J. Li, R. Bhuvananakantham,
J. Lescar, and M.-L. Ng, “Inhibition of West Nile virus entry by
using a recombinant domain III from the envelope glycoprotein,” Journal of General Virology, vol. 86, no. 2, pp. 405–412,
2005.
[32] G. D. Gromowski and A. D. T. Barrett, “Characterization
of an antigenic site that contains a dominant, type-specific
neutralization determinant on the envelope protein domain III
(ED3) of dengue 2 virus,” Virology, vol. 366, no. 2, pp. 349–360,
2007.
[33] J. F. L. Chin, J. J. H. Chu, and M. L. Ng, “The envelope
glycoprotein domain III of dengue virus serotypes 1 and 2
inhibit virus entry,” Microbes and Infection, vol. 9, no. 1, pp. 1–
6, 2007.
[34] K.-C. Huang, M.-C. Lee, C.-W. Wu, K.-J. Huang, H.-Y. Lei,
and J.-W. Cheng, “Solution structure and neutralizing antibody
binding studies of domain III of the dengue-2 virus envelope
protein,” Proteins, vol. 70, no. 3, pp. 1116–1119, 2008.
[35] J. Abd-Jamil, C.-Y. Cheah, and S. AbuBakar, “Dengue virus type
2 envelope protein displayed as recombinant phage attachment
protein reveals potential cell binding sites,” Protein Engineering,
Design and Selection, vol. 21, no. 10, pp. 605–611, 2008.
[36] V. Huerta, G. Chinea, N. Fleitas et al., “Characterization of the
interaction of domain III of the envelope protein of dengue
virus with putative receptors from CHO cells,” Virus Research,
vol. 137, no. 2, pp. 225–234, 2008.
[37] S. M. Erb, S. Butrapet, K. J. Moss et al., “Domain-III FG loop
of the dengue virus type 2 envelope protein is important for
infection of mammalian cells and Aedes aegypti mosquitoes,”
Virology, vol. 406, no. 2, pp. 328–335, 2010.
[38] W. C. Black IV, K. E. Bennett, N. Gorrochótegui-Escalante et al.,
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